The London Clinic has announced a partnership with Datar Cancer Services to provide precision oncology-based solutions to improve the detection and treatment of cancers.
The partnership brings together two organisations that are dedicated to finding better ways to detect and treat cancers for the betterment of patients around the world. Datar Cancer Genetics has been at the forefront in developing greater insight into the cancer ecosystem and offering its molecular and cell analysis-based product services to clinicians and patients globally.
The London Clinic, an independent charitable hospital, has a pioneering cancer treatment centre in its Duchess of Devonshire Wing. This state-of-the-art facility, spanning eight floors, has received its second five-star Quality Environment Mark from Macmillan in 2022. As part of its charitable purpose, The London Clinic remains committed to technological innovation in cancer care and also offers 'Moving On', a free of charge survivorship programme for cancer patients.
Dr. Vineet Datta, executive director, Datar Cancer Genetics, commented: “This collaboration will provide advanced cancer genomics to the patient community, and we will work closely with the oncology team to support better informed clinical decision making.”
Lina Patel, Head of Cancer Services at The London Clinic, said: “We believe that our partnership with Datar Cancer Genetics will provide an excellent platform to offer precision personalised medicine, leading to more patients surviving and hopefully thriving for many years post-treatment. It’s through partnerships like this, with best practice shared openly, that the global heath community will advance clinical excellence.”
